aerosol
The efficacy and       safety of inhaled nedocromil sodium (Tilade Mint aerosol) administered using a       Fisonair spacer at a dose of 4 mg three times daily was compared with placebo in        the treatment of asthmatic children aged 6-12 years who are symptomatic and       recovering from an acute exacerbation of asthma.
The efficacy and       safety of inhaled nedocromil sodium (Tilade Mint  @SUBJECT$ ) administered using a       Fisonair spacer at a dose of 4 mg three times daily was  @PREDICAT$  with  @OBJECT$  in        the treatment of asthmatic children aged 6-12 years who are symptomatic and       recovering from an acute exacerbation of asthma.